Latest period
$312M
YoY change
+36.5%
5Y CAGR
+5.1%
Peak year (FY2025)
$417M
Latest annual
$417M
Total Debt history chart for West Pharmaceutical Services (WST) from 2016 to 2025
Latest: $417M
Total Debt growth chart for West Pharmaceutical Services (WST) from 2016 to 2025
Latest: +36.5%
Total Debt history table for West Pharmaceutical Services (WST) from 1985 to 2025
| FY2025 | $417M | +36.5% | +$111M | ||
| FY2024 | $305M | -1.2% | -$3.7M | ||
| FY2023 | $309M | -2.8% | -$8.9M | ||
| FY2022 | $318M | -2.3% | -$7.4M | ||
| FY2021 | $325M | -0.1% | -$400K | ||
| FY2020 | $326M | -1.1% | -$3.6M | ||
| FY2019 | $329M | +67.9% | +$133M | ||
| FY2018 | $196M | -0.5% | -$900K | ||
| FY2017 | $197M | -13.8% | -$31.6M | ||
| FY2016 | $229M | -23.3% | -$69.6M | ||
| FY2015 | $298M | -11.1% | -$37.3M | ||
| FY2014 | $336M | -10.2% | -$38M | ||
| FY2013 | $374M | -9.2% | -$38M | ||
| FY2012 | $412M | +17.8% | +$62.1M | ||
| FY2011 | $349M | -2.5% | -$9M | ||
| FY2010 | $358M | -5.6% | -$21.2M | ||
| FY2009 | $380M | -1.7% | -$6.4M | ||
| FY2008 | $386M | -2.3% | -$9.1M | ||
| FY2007 | $395M | +67.2% | +$159M | ||
| FY2006 | $236M | -15.9% | -$44.7M | ||
| FY2005 | $281M | +74.8% | +$120M | ||
| FY2004 | $161M | -8.1% | -$14.2M | ||
| FY2003 | $175M | 0.0% | $0.00 | ||
| FY2002 | $175M | -9.3% | -$18M | ||
| FY2001 | $193M | -3.2% | -$6.4M | ||
| FY2000 | $199M | +16.5% | +$28.3M | ||
| FY1999 | $171M | +21.3% | +$30M | ||
| FY1998 | $141M | +58.5% | +$52.1M | ||
| FY1997 | $89M | -9.6% | -$9.4M | ||
| FY1996 | $98.4M | -13.9% | -$15.9M | ||
| FY1995 | $114M | +97.8% | +$56.5M | ||
| FY1994 | $57.8M | +78.9% | +$25.5M | ||
| FY1993 | $32.3M | -23.3% | -$9.8M | ||
| FY1992 | $42.1M | -27.9% | -$16.3M | ||
| FY1991 | $58.4M | -25.6% | -$20.1M | ||
| FY1990 | $78.5M | +35.1% | +$20.4M | ||
| FY1989 | $58.1M | +5.4% | +$3M | ||
| FY1988 | $55.1M | -8.9% | -$5.4M | ||
| FY1987 | $60.5M | +36.6% | +$16.2M | ||
| FY1986 | $44.3M | +45.7% | +$13.9M | ||
| FY1985 | $30.4M | — | — |
- FY2025$417M+36.5%
- FY2024$305M-1.2%
- FY2023$309M-2.8%
- FY2022$318M-2.3%
- FY2021$325M-0.1%
- FY2020$326M-1.1%
- FY2019$329M+67.9%
- FY2018$196M-0.5%
- FY2017$197M-13.8%
- FY2016$229M-23.3%
- FY2015$298M-11.1%
- FY2014$336M-10.2%
- FY2013$374M-9.2%
- FY2012$412M+17.8%
- FY2011$349M-2.5%
- FY2010$358M-5.6%
- FY2009$380M-1.7%
- FY2008$386M-2.3%
- FY2007$395M+67.2%
- FY2006$236M-15.9%
- FY2005$281M+74.8%
- FY2004$161M-8.1%
- FY2003$175M0.0%
- FY2002$175M-9.3%
- FY2001$193M-3.2%
- FY2000$199M+16.5%
- FY1999$171M+21.3%
- FY1998$141M+58.5%
- FY1997$89M-9.6%
- FY1996$98.4M-13.9%
- FY1995$114M+97.8%
- FY1994$57.8M+78.9%
- FY1993$32.3M-23.3%
- FY1992$42.1M-27.9%
- FY1991$58.4M-25.6%
- FY1990$78.5M+35.1%
- FY1989$58.1M+5.4%
- FY1988$55.1M-8.9%
- FY1987$60.5M+36.6%
- FY1986$44.3M+45.7%
- FY1985$30.4M—
Total Debt values are taken from West Pharmaceutical Services's reported balance sheets (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About Total Debt at West Pharmaceutical Services (WST)
According to West Pharmaceutical Services's latest reported financial statements, the company's latest reported total debt is $312M. Total debt is the sum of short-term and long-term interest-bearing borrowings on the balance sheet (notes, bonds, term loans, lease liabilities). Useful for leverage and refinancing risk — compare with cash on hand for net leverage, and total liabilities for the broader obligations picture.
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
In 2025, West Pharmaceutical Services (WST) total debt totalled $417M – surged 36.5% year-over-year.
Through 2020–2025 (5 years), West Pharmaceutical Services total debt delivered a +5.1% annualised rate; with mixed annual results across the window.
$417M stands as the all-time-high annual total debt, posted in 2025, against a low of $30.4M during 1985.
West Pharmaceutical Services Total Debt by Year
West Pharmaceutical Services Total Debt 2025: $417M
2025's total debt for West Pharmaceutical Services came in at $417M, surged 36.5% from 2024. This figure represents the highest annual value in the available history.
West Pharmaceutical Services Total Debt 2024: $305M
West Pharmaceutical Services posted total debt of $305M in 2024, edged down 1.2% below 2023.
West Pharmaceutical Services Total Debt 2023: $309M
In 2023, West Pharmaceutical Services reported total debt of $309M, edged down 2.8% below 2022.
West Pharmaceutical Services Total Debt 2022: $318M
West Pharmaceutical Services total debt in 2022 was $318M, edged down 2.3% below 2021.
West Pharmaceutical Services Total Debt 2021: $325M
West Pharmaceutical Services total debt in 2021 was $325M.
See more financial history for West Pharmaceutical Services (WST).
Sector peers by Total Debt
Healthcare peers of West Pharmaceutical Services (WST), ranked by their latest total debt
| $78.4B | |
| $69.1B | |
| $54.6B | |
| $50.5B | |
| $47.9B | |
| $42.5B | |
| $40.9B | |
| $20.6B |
- $78.4B
- $69.1B
- $54.6B
- $50.5B
- $47.9B
- $42.5B
- $20.6B
Frequently asked questions
West Pharmaceutical Services (WST) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation
- Buybacks2.34% TTM
- Dividend Profile0.32% yield
- Dividend Calculator
- Dividend Forecast
- Dividend Capture
- Stock Split History4 splits
How this company returns cash to shareholders — buybacks, dividends, and stock splits.